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The crystal structure of HIV-1 Nef protein bound to the Fyn
kinase SH3 domain suggests a role for this complex in altered 
T cell receptor signaling
Stefan Arold1†, Peet Franken1†, Marie-Paule Strub1, Francois Hoh1, 
Serge Benichou2, Richard Benarous2 and Christian Dumas1*
Background: Human immunodeficiency virus (HIV) Nef protein accelerates
virulent progression of acquired immunodeficiency syndrome (AIDS) by its
interaction with specific cellular proteins involved in signal transduction and
host cell activation. Nef has been shown to bind specifically to a subset of the
Src family of kinases. The structures of free Nef and Nef bound to Src
homology region 3 (SH3) domain are important for the elucidation of how the
affinity and specificity for the Src kinase family SH3 domains are achieved, and
also for the development of potential drugs and vaccines against AIDS.
Results: We have determined the crystal structures of the conserved core of
HIV-1 Nef protein alone and in complex with the wild-type SH3 domain of the
p59fyn protein tyrosine kinase (Fyn), at 3.0 Å resolution. Comparison of the
bound and unbound Nef structures revealed that a proline-rich motif (Pro-x-x-
Pro), which is implicated in SH3 binding, is partially disordered in the absence
of the binding partner; this motif only fully adopts a left-handed polyproline type
II helix conformation upon complex formation with the Fyn SH3 domain. In
addition, the structures show how an arginine residue (Arg77) of Nef interacts
with Asp100 of the so-called RT loop within the Fyn SH3 domain, and triggers
a hydrogen-bond rearrangement which allows the loop to adapt to complement
the Nef surface. The Arg96 residue of the Fyn SH3 domain is specifically
accommodated in the same hydrophobic pocket of Nef as the isoleucine
residue of a previously described Fyn SH3 (Arg96→Ile) mutant that binds to
Nef with higher affinity than the wild type.
Conclusions: The three-dimensional structures support evidence that the
Nef–Fyn complex forms in vivo and may have a crucial role in the T cell
perturbating action of Nef by altering T cell receptor signaling. The structures of
bound and unbound Nef reveal that the multivalency of SH3 binding may be
achieved by a ligand induced flexibility in the RT loop. The structures suggest
possible targets for the design of inhibitors which specifically block Nef–SH3
interactions.
Introduction
Infection by human immunodeficiency virus HIV-1 is
associated with quantitative and qualitative T cell alter-
ations that severely weaken the host’s immune defence
system and finally cause acquired immunodeficiency syn-
drome (AIDS). The molecular basis for this immuno-
suppression remains undefined.
Encoded at the 3′-end of the genome, the nef gene [1] of
primate immunodeficiency viruses HIV-1, HIV-2 and
simian immunodeficiency virus (SIV) is an important
determinant of virulence in experimental infection of adult
monkeys and in human disease [2–6]. A nef-deleted mutant
of SIV which does not cause disease in adult macaques has
been successfully used as a vaccine against challenge with
pathogenic viruses, but causes AIDS in neonatal animals
[7,8]. The critical role of Nef in human infection by the
HIV-1 virus was also supported by studies of long term
nonprogressing subjects infected with attenuated virus
strains manifesting deletions in the nef gene [9,10].
The Nef viral molecule is a 206 amino acid N-terminal
myristoylated protein [1,11] of 27 kDa, found in the cyto-
plasm and predominantly associated with the plasma
membrane. Nef is one of the first HIV proteins to be pro-
duced at high levels in infected cells and the most
immunogenic of the regulatory proteins [2,3]. Several
recent reports provide evidence that Nef is a virion-associ-
ated protein, specifically cleaved in the viral particle by
the viral protease to form a stable core domain [12–15]. 
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Currently, three putative functions can conceivably account
for the effects of Nef: down-regulation of the surface
expression of CD4 [16–18], the principal viral receptor in T
cells, and of major histocompatibility complex (MHC) I
molecules [19]; modulation of the T-cell activation status
[6,20–22]; and enhancement of viral growth rate and infec-
tivity [23–25]. The molecular mechanisms by which these
actions are accomplished remain elusive. Promotion of
viral growth and CD4 down-regulation are functionally and
genetically independent [25–27]. A correlation between
direct Nef–protein kinase association and increase in infec-
tivity has been shown [26,28]. Nef was reported to bind to
serine/threonine kinases [28–30] and to various members
of the Src family of protein tyrosine kinases: Hck and Lyn
[26,31], Lck [32,33] and Fyn [33]. 
All these Src kinases are intricately linked in signal trans-
duction pathways that control growth and cellular architec-
ture [34,35]. Both Src-related protein tyrosine kinases
p59fyn (Fyn) and p56lck (Lck) are abundantly expressed in
T lymphocytes and have been implicated in antigen-
induced T-cell activation [36–39]. Fyn is associated with
the T cell antigen receptor (TCR) and plays an important
role in TCR-mediated signaling. Hck shows restricted
tissue distribution with expression in haematopoietic cells
from the monocyte/macrophage lineage.
A Pro-x-x-Pro motif, known as classical Src homology
region 3 (SH3) domain binding consensus, is found to be
strictly conserved in HIV Nef isolates [26,31]. The 60
residue SH3 domain is present in a number of signal trans-
duction and cytoskeletal proteins [40]. Within Src family
tyrosine kinase members, the SH3 domains have approxi-
mately 60% identical sequences and they mediate direct
substrate recognition, regulate kinase activity and control
subcellular localisation [34]. The PxxP binding motif of
SH3 domains present in Nef plays a critical role in
enhancing viral replication [26].
The SH3 domain of Hck was reported to bind to Nef with
an approximately 100-fold higher affinity than to the Fyn
SH3 domain [31]. A single amino acid substitution in the
Fyn SH3 domain (Arg96→Ile, as found in Hck) restored
the high affinity of the Hck SH3 domain [31]. The struc-
ture of the HIV-1 NL43 isolate (HIV-1NL43) Nefcore region
complexed to the R96I ‘Hck-like’ mutant Fyn SH3 domain
has been published recently [41]. The expression of Hck
kinase, however, is restricted to myeloid cells [42,43]; the
Hck–Nef interaction can therefore not account for signal-
ing defects in T lymphocytes. This fact highlights the
importance of further identification of cellular partners of
Nef in HIV target cells. The Fyn protein tyrosine kinase
is expressed in T cells and could potentially be one of the
physiological targets of Nef in HIV-infected CD4+ lym-
phocytes. We have initiated crystallographic studies in
order to address this question. 
Our structural studies of HIV-1LAI Nef (from the LAI
isolate) have focused on the central core domain
(residues 58–206). This stable domain contains the inter-
action site for SH3 domains and corresponds to the
product of HIV-1 protease cleavage [14,15,44]. We report
here the first crystal structure of the core domain of unli-
ganded HIV-1LAI Nefcore. The overall fold of the unli-
ganded Nefcore molecule is very similar to the solution
structure of unliganded HIV-1BH10 Nef∆2-39,∆159-173,T71R
protein [45,46]. In addition, we have solved the crystal
structure of the HIV-1LAI Nefcore in complex with the
human wild-type Fyn SH3 domain at 3.0 Å resolution
and compared it with the crystal structure of HIV-1NL43
Nefcore bound to the high affinity R96I mutant of the Fyn
SH3 domain [41]. The polyproline region (residues
71–77) of the unliganded Nefcore molecule is partially dis-
ordered in the crystal structure, suggesting the PxxP
motif is intrinsically flexible without bound SH3 domain.
The comparison of the Fyn SH3 domain in the free state
[47] and in our complex reveals that Nef induces local
rearrangements in the hydrogen-bond network that holds
a loop of the SH3 domain (termed the RT loop) in a rigid
conformation. We show that the arginine residue at posi-
tion 96 in the wild-type SH3 domain of Fyn is specifi-
cally accommodated in the same hydrophobic pocket of
Nef as Ile96 in the previously reported structure of the
high-affinity mutant of Fyn SH3 [41]. The interface
buried between adjacent Nef molecules in the crystals is
relatively large, about 8% of the total accessible surface
of each molecule, and may provide a structural basis for
the oligomerization of Nef reported by several authors
[41,46,48,49]. The data presented here supports the idea
that the complex between Fyn kinase and Nef could be
biologically relevant in HIV-infected T cells.
Results and discussion
Overall structure of the HIV-1LAI Nefcore
We describe here three independent Nefcore molecules
from two different crystal forms at 3.0 Å resolution: two
unbound Nef molecules in hexagonal and cubic crystal
forms (Nef-A and Nef-C, respectively; see Materials and
methods section), and the SH3-liganded Nef molecule in
hexagonal crystal form (Nef-B). The common overall struc-
ture of the core domain of HIV-1 Nef protein (residues
58–206, LAI isolate) (Figure 1) is essentially identical to
the crystal structure of SH3-liganded Nef (residues
54–205) from the HIV-1 NL43 isolate [41] and to the solu-
tion structure of unbound Nef∆2-39,∆159-173,T71R from the
HIV-1 BH10 isolate [45,46]. The core domain folds into
an α/β structure with four antiparallel β strands (sequen-
tially labelled βA, 126–129; βB, 134–137; βC, 142–148; and
βD, 180–185) flanked by an asymmetric distribution of
four α helices. Two antiparallel helices, αA (residues 81–
93) and αB (residues 104–118), cluster together proximate
to one face of the central β sheet. The left-handed poly-
proline type II (PPII) helix, in the N-terminal region
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(residues 71–77) is packed against the C-terminal part of
helix αB. As pointed out by Lee et al. [41], geometrical
distortion of the central β sheet is due to the presence of
two conserved proline residues in strands βB (Pro136) and
βC (Pro147), and to the limited number of residues
involved in hydrogen bonds between these two interior
strands. The N-terminal region from residue 58 to the
polyproline motif, and the loop (residues 149–178) con-
necting strands βC–βD are disordered and not visible in
the electron-density map. 
The structure of the liganded Nef-B molecule (hexagonal
crystal form) can be superimposed on the unliganded Nef-
A (hexagonal crystal form) and Nef-C (cubic crystal form)
with an overall root mean square (rms) deviation in Cα
coordinates of 0.59Å and 0.78 Å, respectively, indicating
that Nef does not undergo drastic structural changes upon
complex formation. The temperature factors of the residues
in the unbound Nef-A and Nef-C structures show mostly
the same pattern as the temperature factors of the lig-
anded Nef-B structure. 
Polyproline II conformation in the unliganded Nef core
The most striking structural feature of the unliganded
Nef core domain appears to be the partly disordered con-
formation of the polyproline region (residues 71–77).
Both ligand-free Nef molecules (Nef-A and Nef-C) lack
interpretable electron density for the N-terminal region
(residues 58–73) including the PPII helix motif, whereas
the polypeptide chain in the SH3-liganded form (Nef-B)
could be traced up to residue 71. The second half of the
polyproline region (residues 74–77) is anchored through
hydrogen bonding to the Nef core domain (residues
118–121) and shows higher temperature factors (average
B factors 52 A2) in the unliganded Nef forms than in the
liganded Nef-B molecule (average B factors 28 A2).
These results seem to support that the polyproline region
is partially disordered without a binding partner, suggest-
ing it is intrinsically flexible. This region containing the
PxxP motif, therefore, is not presented for interaction
with the SH3 domain in the preferred left-handed PPII
helix conformation. It is the SH3 domain that restrains its
flexibility and stabilizes the PPII helix conformation upon
complex formation. These structural findings are compat-
ible with backbone dynamics and internal mobility in this
polyproline region of unliganded Nef as calculated from
NMR data [46].
Structure of the Nef–Fynwt SH3 complex
The basic fold of the Fyn SH3 domain (residues 85–141;
Figure 2a) is similar to that described for the various Fyn
SH3 domains whose structures, in the presence or absence
of a ligand peptide, have been reported using X-ray 
crystallography and NMR spectroscopy [47,50–52]. The
Fyn SH3 domain shows the highly conserved SH3 topol-
ogy consisting of a β barrel formed by two approximal
orthogonal β sheets, each composed of three antiparallel β
strands. The N-terminal part of the Fyn SH3 domain is
disordered before residue 84. The three connecting loops
between the β strands are assigned as the distal, n-src and
RT loops [47,50]. The Cα coordinates of the Fynwt SH3
domain complexed to Nef can be superimposed within
0.48 Å rms deviation to the X-ray structure of the
unliganded Fyn SH3 domain (molecule A of PDB entry
1SHF) [47]. The relative orientation of the SH3 domain
with respect to Nef (Figure 2 is identical to that described
for the Nef–FynR96I SH3 complex [41]: Cα coordinates for
157 pairs can be superimposed within 0.65 Å rms devia-
tion (complex 2 in PDB entry 1EFN).
Most of the Fyn SH3 residues implicated in Nefcore binding
(Figure 3; Table 1) are strictly conserved among the Src
kinase members listed. The Nef–Fyn SH3 complex forms
via hydrophobic interactions, hydrogen bonds and specific
electrostatic interactions. The Nef polyproline region
(residues 71–77; coloured in blue in Figure 2b) including
residues Pro72 and Pro75, packs on to aromatic residues of
the SH3 domain as described for SH3–peptide complexes
[50–53]. Nef forms additional tertiary interactions (yellow
surface on Nef; Figure 2b) involving residues Lys82, Ala83,
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Figure 1
Ribbon diagram of the unliganded Nefcore domain (residues 71–148
and 179–206). The polyproline type II helix is shown at the top of the
figure in pink (residues 71–77) and is disordered before residue 74
(pink dotted line). This helix is followed by two antiparallel α helices
(αA and αB) and a layer of four β strands (βA–βD) with a disordered
loop connecting strands βC and βD (residues 149–178, not visible in
the crystal structure). Finally, there are two short α helices (αC and
αD) at the C terminus. (The figure was created with the programs
MOLSCRIPT [71] and RASTER3D [72].)
Asp86, Leu87 and Phe90 of the αA helix residues Trp113,
Thr117 and Glu118 of the αB helix and Tyr120 of the
loop connecting the αB helix to strand βA. Regarding
Fyn, most residues in contact with Nef and all those
which form the specificity determinating bounds with
non-PxxP residues of Nef, are situated in the RT loop
(Figures 2b and 3). At least, three distinct regions on the
surface of the Fyn SH3 domain are involved in the Nef
interface. Most of these regions are conserved in other Src
family kinases: a predominant aromatic cluster compris-
ing residues Tyr91 and Tyr93 (labels a and b in Figure 3)
followed by residues 97–100 (labels c to g) which map in
the middle of the RT loop: the conserved Trp119 residue
(label h); and the Pro-x-Asn-Tyr motif in the 310-helix
region (labels i, j and k).
The accessible surface areas of the isolated Nefcore and
Fynwt SH3 domain are 6430 Å2 and 3760 Å2, respectively.
As a result of complex formation, some of the surface area
is buried in the interface between both molecules. The
total buried surface area involved in the interface repre-
sents 1270 Å2, with 630 Å2 and 640 Å2 for SH3 and Nef,
respectively. All these values are within the usual range
for protein complexes and comparable to those described
for the Nefcore–FynR96I SH3 complex [41]. The values
obtained for the buried surface area establish that the
interacting surface of Nef can be sufficiently large to form
a stable complex with the Fynwt SH3 domain. The contri-
bution of each residue to the buried solvent-accessible
surface is shown in Figure 4. In the Nefcore domain, the
most important contribution to the interface area comes
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Figure 2
Structure of the HIV-1 Nefcore–Fynwt SH3
complex. (a) Ribbon drawing of the Nefcore
domain complexed to the Fynwt SH3 domain.
The wild-type Fyn SH3 domain is shown at the
top in yellow and comprises a β barrel
consisting of five antiparallel β strands which
form two perpendicular β sheets. The
polyproline type II helix of Nef is shown in pink.
The limits of the disordered loop region
(residues 149–177) are indicated by dotted
lines. (The figure was prepared using
MOLSCRIPT [71] and RASTER3D [72].) 
(b) Molecular surface representation of the
HIV-1 Nefcore domain and the Fyn SH3
backbone worm (grey). The views in (a) and (b)
are approximately orthogonal. The Nef surface
representation shows the polyproline type II
helix (residues 71–77) in blue and the other
residues involved in binding of the Fyn SH3
domain (K82, A83, D86, L87, F90, W113,
T117, Q118 and Y120 ) in yellow. Arg96 and
Asp100, critical residues within the RT loop of
the Fyn SH3 domain are shown in red. (The
figure was produced using GRASP [73].)
Figure 3
Assignment of secondary structure elements
of the Fyn SH3 domain and alignment of the
known human amino acid sequences of the
Src protein tyrosine kinase family. Fyn SH3
residues involved in the Nef–SH3 interface
(letters a–k), and homologous aligned
residues, are enclosed in shaded boxes.
Strictly conserved residues implicated in Nef
core binding are labelled b, g, h, i and j (see
text for details). The amino acid numbering
corresponds to p59fyn.
Hck  IV-- ------IHHE----Q--D QMVVLE E-.-E --K--- -A-RK E--- ---- --R --   62
Fyn  LFVA LYDYEARTEDDLSFHKGE KFQILN SSEGD WWEARS LTTGE TGYI PSNY VAP VD  100
90
|
100
|
110
|
120
|
130
|
140
| Sequence
identity (%)
Lyn  IV-- --P-DGIHP-----K--- -MKV-E EH.-E --K-K- -L-KK E-F- ---- --K LN   56
RT loop n–Src loop Distal loop
a b  cdefg                     h                 i jk
Lck  -VI- -HS--PSHDG--G-E--- QLR--E Q-.-E --K-Q- ----Q E-F- -F-F --K AN   50
Src  T--- -----S---T----K--- RL--V- NT--- --LAH- -S--Q ---- ---- --- S-   75
Yes  I--- --------TE----K--- R---I- NT--- ------ IAT-K N--- ---- --- A-   76
Frg  --I- ------------T-T--- --H--- NT--- ------ -SS-K --CI ---- --- --   83
Blk  FV-- ----TAMNDR--QML--- -L-VLK GT.-- --L--- -V--R E--V ---F --- -E   61
Structure
Aβ βB βC 310βD βE
from residues Pro72, Val74, Pro75, Arg77 of the PPII helix
and Asp86 of helix αA. The residues of the Fyn SH3
domain that make the largest contributions to the buried
solvent-accessible area are Arg96 and Trp119, providing
160 Å2 and 100 Å2, respectively. All the calculations of
buried surface utilized a 1.4 Å probe radius.
Nef induces a conformational change in the Fyn SH3 RT
loop
Flexibility in protein surface loops plays an important
role in molecular recognition. Conformational gating can
provide a mechanism to increase ligand specificity by
‘induced fit’. In the unbound Fyn SH3 domain [47,52],
the conformation of the RT loop (residues 90–108) is sta-
bilized in a rigid conformation by a hydrogen-bonding
network (Figure 5a). An important component of this
hydrogen-bond network is the Asp100 residue. As illus-
trated in Figure 5a, Asp100 plays a pivotal role: its car-
boxylate group positioned in the centre of the RT loop
serves to anchor the sidechains of Tyr93 and Thr97 as
well as the mainchain of Thr97 and Arg96 through five
hydrogen bonds. The stabilized RT loop is fixed by two
additional hydrogen bonds to residue Tyr132 of the
underlying strand βD.
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Table 1
Residues involved in the HIV-1LAI Nef–Fynwt SH3 interaction.
Fyn Nef Interactions
Label Residue
RT loop a Y91 P72 Hydrophobic 
b Y93 V74 Hydrophobic 
c R96 F90, W113, I114 Hydrophobic 
T117 Hydrogen bond R96 NH2 to T117 Oγ1
d T97 Y120 Hydrogen bond T97 Oγ1 to Y120 OH
e E98 D86 Hydrogen bond E98 N to D86 Oδ1
f D99 K82 Salt bridge 
g D100 R77 Salt bridge
β Strand C h W119 P75 Hydrogen bond W119 Nε1 to P75 O
V74, R77 Hydrophobic 
310 Helix i P134 P75 Hydrophobic 
j N136 Q73 Hydrogen bond N136 Nδ2 to Q73 O
k Y137 P72 Hydrogen bond Y137 OH to P72 O
V74 Hydrophobic
The SH3 labels a to k correspond to the convention of Figure 3. Nef residues of the polyproline region are indicated in bold letters. A distance cut-
off of 3.6 Å was used for possible hydrogen bonds; for hydrophobic interactions, a distance cut-off of 4.0 Å was used. 
Figure 4
Loss of solvent-accessible surface area of the
sidechain residues involved in the Nef–Fynwt
SH3 interface. Solvent accessibilities were
calculated with a rolling sphere of radius
1.4 Å.
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Structure
The strictly conserved residue Arg77 in the P-3 position
[31] of the Nef polyproline region plays a key role in the
Nef–SH3 interfacial electrostatic interaction. Arg77 is
anchored to the Nefcore domain via hydrogen bonds to the
mainchain atoms of residues 118, 119 and 120. In the
absence of a ligand, Arg77 already partially locks residues
75–77 in a PPII helix conformation and is held in an
optimal position for interaction with SH3 domains. Upon
binding to the Fyn SH3 domain, Arg77 reaches out for
Fyn SH3 Asp100 and bends it away from its central posi-
tion in the RT loop by the formation of a salt bridge
(Figure 5b). Similar ion pairing interactions have been
described in SH3–peptide complexes [50–53]. The dis-
placement of Asp100 results in the disruption of all of its
three hydrogen bonds to mainchain nitrogens (Figure 5b).
This loss of the stabilizing hydrogen bonds renders the
stretch of residues 95–101 of the RT loop floppy enough
to adapt to the Nef surface. In particular, this flexibility
enables the large displacement of Arg96 (1.4 Å displace-
ment for the Cα atom, and 8 Å for the guanidinium
group), that is necessary to stack its aliphatic moiety onto
the Phe90 residue which is localized in a crevice on the
surface of Nef. This mechanism of introduced flexibility
may provide an explanation for the ability of the Nef
protein to bind to different SH3 target molecules.
Hot spots of binding energy in the Nef–SH3 interface
Tertiary interactions seem to be a common mechanism by
which relevant levels of specificity are achieved. Nef forms
a high-affinity complex with the FynR96I SH3 domain
(KD = 380 nM) whereas a lower affinity (KD > 20 µM) was
reported for wild-type Fyn SH3 [26,31]. The superimposi-
tion of the Nef–Fynwt SH3 structure with the structure of
Lee et al. [41] (Figure 6), shows that Arg96 mimics Ile96 of
the R96I mutant Fyn SH3 domain. In a similar manner to
Ile96, Arg96 presents its aliphatic moiety to the Nef
hydrophobic cavity comprising residues Leu87, Phe90 and
Trp113. The Nη1 atom of the Arg96 guanidino group
replaces a bound water molecule in the model of Nef–
FynR96I SH3 [41]. The Ile96 sidechain and polymethylene
chain of Arg96 are fully buried at the interface, but the
charged guanidinium group of Arg96 is partially exposed
to the solvent (25 Å2 of solvent accessible surface). An
acidic residue in the vicinity of Arg96 (SH3 Glu94) con-
tributes to electrostatic complementarity. Thus, the
complex between Nef and the wild-type SH3 domain of
Fyn reveals that the sidechain of Arg96 fits into the
hydrophobic pocket of Nef as does Ile96 of the Fyn SH3
mutant, and does not seem to result in an energetically
unfavourable situation. The reported loss in binding free
energy of about 2.3 kcal mol–1 for the wild-type SH3
domain cannot be explained by the structure alone and
may result from partial desolvation and entropic penalties
due to the rearrangement of the Arg96 sidechain.
The above mentioned Asp100 residue of the SH3 domain
and Arg77 residue of Nef are strictly conserved in both
molecules and engage in the formation of a salt bridge.
This electrostatic interaction is a prominent feature of
peptide–SH3 interactions [50–53], and may constitute a
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Figure 5
Conformational rearrangement in the Fyn SH3 RT loop upon binding to
the Nefcore domain. (a) The RT loop region of unliganded Fyn SH3 (PDB
entry 1SHF) [46] in stick representation. Atoms are coloured by type: C,
yellow; N, blue; O, red. Asp100 plays a pivotal role in maintaining a
network of hydrogen bonds (indicated by dashed lines). The RT loop is
fixed to Tyr132 of the underlying β strand. (b) Superimposition of the RT
loop region of the unliganded (yellow) and liganded (pink) Fyn SH3
domain, shown as an all-atom stick figure. Sidechains of residues not
involved in binding are omitted for clarity; Nef residues are indicated by
an asterisk. Residues not represented in the figure are shown boxed.
Large displacements were observed for Fyn residues Arg96 and
Asp100, which forms a salt bridge to Nefcore Arg77.
second ‘hot spot’ of binding energy. In the present struc-
ture, Nef Arg77 is stacked against the Nef Trp119 side-
chain. The molecular surfaces of these residues are largely
buried upon complex formation (Figure 4), indicating an
additional key contribution to the hydrophobic core of the
functional epitope. The electrostatic interaction between
Nef Arg77 and SH3 Asp100 in the RT loop also serves to
position the SH3 Arg96 sidechain inside the hydrophobic
crevice on the surface of Nef. Further evidence regarding
the importance of these residues has been provided by
biochemical and mutational experiments describing altered
SH3 binding affinity as a result of the substitution of these
residues [54].
A precise evaluation of the contribution of these residues to
the stability of the complex would require high-resolution
structure determination for both liganded and unliganded
Nef molecules, and thermodynamic measurements.
Sequence variability in the polyproline region of Nef
Sequence comparison of various Nef isolates shows that
the core domain of Nef (excluding the disordered
βC–βD) is well conserved [15,41]. Most of the strictly
conserved positions in the Nefcore domain are clearly
implicated either in stabilizing the hydrophobic core or
binding the SH3 domain [41]. The LAI strain used in this
paper has a threonine residue at position 71. Unlike this
laboratory adaptated HIV-1 strain, almost all nef alleles
isolated directly from patients encode an arginine or a
lysine at position 71 rather than a threonine [55,56]. As
shown in Figure 7, the threonine sidechain does not form
any major contacts with the SH3 domain in the proximity
of Tyr137. In contrast, the Arg71 residue in the crystal
structure of Lee et al. [41] enhances the stability of the
complex by forming a hydrogen bond with the hydroxyl
group of Tyr137 and electrostatic interactions with acidic
residues Asp92 and Glu94 of Fyn SH3 (Figure 7). In the
Lee et al. structure, mainchain atoms of Arg71 and Pro72
in Nef, as well as Tyr91 in the SH3 domain, are signifi-
cantly displaced (about 0.9 Å) relative to the position in
our complex. These observations are compatible with the
results of previous studies showing significantly increased
binding affinity of Lyn and Hck SH3 to the NefT71R
mutant [26]. The gain in affinity for the Arg71 strains may
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Figure 6
Arg96 of Fynwt SH3 domain in its simulated annealing (2Fo–Fc) electron
density omit map [63] contoured at 1.1σ. The residues of the wild-type
Fyn SH3 (yellow) and HIV-1LAI Nef (purple) are superimposed onto
FynR96I SH3 (orange) and HIV-1NL43 Nef (grey; PDB entry 1EFN) [41].
Hydrogen bonds are drawn as dashed lines. A water molecule hydrogen
bonded to HIV-1NL43 Nef is represented by an orange CPK sphere.
Figure 7
Superimposition of the crystal structures of
Nef–SH3 complexes. Stereoview of the
interface showing the environment of the Nef
polyproline type II helix region (residues
71–77) and conserved residues. The two Nef
isolates are superimposed: Nef HIV-1LAI
isolate in green and NefT71R HIV-1NL43 isolate
(Nef-D molecule in PDB entry 1EFN) in red.
The hydrogen bond between the Arg71
sidechain and Tyr137 of FynR96I is shown as a
dotted white line. The SH3 domains are
coloured in light purple and dark purple for
Fynwt and FynR96I (SH3-C molecule in PDB
entry 1EFN), respectively. (Figure generated
using the program O [69].)
explain why in many isolates mutational pressure is
directed from threonine to arginine or lysine.
Crystal packing and the oligomeric structure of HIV-1 Nef
The interface between adjacent Nefcore molecules in both
crystal forms is large (~8% of the total surface) and may be
interpreted as Nef forming dimers and trimers, for the
hexagonal and cubic crystal forms, respectively. In the
hexagonal crystal form, the contact formed between Nef
molecules related by the local axis involves residues located
in the αB helix and the αB–βA loop. The majority of the
contacts are made by hydrophobic residues: Ile109,
Leu112, Tyr115 and Phe121. Most of these residues are
conserved among HIV-1 Nef isolates. The association of
the two Nef molecules buries a surface area of 900 Å2. In
the more densely packed P23 crystal, the trimer interface of
the unliganded Nef covers 1680 Å2 of the solvent-accessible
surface (i.e. ~9% of the monomer surface). Moreover,
oligomer formation will be favoured in the intact cell
because the myristoylated Nef molecules are tethered to
the membrane. The above described packing contacts for
Nefcore domains may be either crystal artefacts, or corre-
spond to ‘crystal oligomers’ [57] which may have formed in
solution before crystallization. Additional evidence for the
formation of Nef dimers, trimers and oligomers has been
reported previously [48,49] and it has been suggested that
these multimers may have a biological function. Neverthe-
less, the cellular role, if any, of Nef oligomerization remains
to be determined. 
The asymmetric unit of the Nef–Fyn SH3 cocrystals con-
tains two Nefcore molecules and one SH3 domain (i.e. one
Nef–SH3 complex and a free Nef molecule). This crystal
packing is characterized by a high solvent content (70%).
It is very likely that the disordered additional 16 N-termi-
nal residues of our Fyn construction sterically hinder the
inclusion of the second SH3 domain. Furthermore, the
stoichiometry of Nef:Fyn SH3 mixture was adjusted to
1.3:1 for optimal crystal growth. Although rarely observed,
a similar packing constraint was described for the p53
tumor suppressor–DNA complex [58], where both one
free and two DNA-liganded p53 molecules were present
in the asymmetric unit.
Functional implications of the Nef–Fyn kinase interaction
in T cells 
The Src family protein tyrosine kinase, Fyn, is expressed
in T cells and is crucially involved in the initiation of TCR
signal transduction [34,35]. Several studies support the
importance of a functional association of Fyn with TCR
machinery. The mechanisms by which Fyn regulates
TCR/CD3 signaling, however, are still not completely
understood. Many cellular proteins associate with Fyn in
T cells, including ZAP-70 [59], CD43 [60] and Fas protein
[61]. Fyn has specific targets which are rapidly phosphory-
lated at tyrosine residues following TCR stimulation [62].
Recent genetic and biochemical studies [20] have shown
that Nef blocks a receptor-proximal event in the TCR/
CD3 pathway, and that this effect is mediated by the
interaction of Nef with a specific SH3 domain present in
the TCR complex. Combined with these experiments,
our structural data support the identification of Fyn SH3
as the candidate target of Nef in T cells and strengthen
the hypothesis that the complex of Nef with the wild-type
Fyn kinase forms in vivo. Aberrant TCR-mediated signal-
ing may involve dysfunctional regulation of Fyn by Nef.
The Src family kinases share common structural features
and regulation. The recent observation that Nef can stim-
ulate Hck kinase in vitro [63] suggests that Nef–SH3
interaction can destabilize the repressed conformation of
Hck [64]. This SH3-dependent activation of Src kinases
may be a general property of Nef.
The interaction of Nef with the TCR machinery is likely
to be critical for AIDS pathogenesis. The resulting alter-
ation in the T-cell activation status and perturbations in
TCR-mediated signaling may lead to an increase in virus
production and contribute to the immune unresponsive-
ness of infected T cells.
Biological implications
The nef gene of human immunodeficiency virus (HIV)
and simian immunodeficiency virus (SIV) encodes a 27
to 34 kDa myristoylated protein. Expression of the HIV
Nef protein has been linked to both decreased cell surface
expression of CD4, the principal HIV receptor in T cells,
and an impairment of signal transduction in these infected
cells. Moreover, the nef gene is required for the induction
of AIDS. Immunization of adult macaques with live
attenuated SIV lacking the nef gene has been shown to
protect against challenge with full-length pathogenic
SIV. It is clear, therefore, that Nef protein plays a key
role in human infection by HIV. 
A proline-rich motif (Pro-x-x-Pro) has been found to be
strictly conserved in all Nef proteins from HIV and SIV
isolates. These PxxP motifs are recognized by Src homol-
ogy 3 (SH3) signaling domains, and Nef has been shown
to bind to a subset of SH3 domains from members of the
Src family of protein tyrosine kinases. The Fyn tyrosine
protein kinase is expressed in T cells and has been pro-
posed as one of the physiological targets for Nef in
infected cells. The results reported in this study have gone
some way towards addressing this question.
The crystal structures of unliganded and Fyn SH3-
bound Nef core molecules provide new insights into the
mode of action of Nef, as well as delineating the struc-
tural features, in both the viral protein and the SH3
domain, which govern the specificity and potency of this
interaction. The N-terminal region of the Nef core
domain containing the PxxP motif is partially disordered
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in the absence of bound ligand, and only fully adopts a
left-handed polyproline type II helix conformation upon
binding to the SH3 domain. Nef interacts with the SH3
domains of the Hck and Fyn protein kinases in struc-
turally similar yet energetically distinct manners. Hck
is not expressed in T cells and its association with Nef
therefore cannot account for the signaling defects
observed in these cells. The reported structures provide
evidence that the Nef–Fyn kinase complex forms in vivo:
both proteins coexist in HIV-infected T cells and are tar-
geted to the membrane by myristoylation; and the Nef
surface that interacts with the Fyn SH3 domain is highly
conserved across HIV-1 isolates. The Fyn protein
kinase is critical in T-cell receptor (TCR)-mediated acti-
vation of T cells. The direct interaction between Nef and
Fyn could partially explain the alteration in the T-cell
activation status and aberrant TCR-mediated signaling
which are observed in HIV-infected T lymphocytes.
Molecules which block specific Nef–Fyn SH3 contacts
could prove to be useful therapeutic agents. In addition,
the identification of HIV peptide epitopes is essential for
AIDS vaccine development and this is of particular
importance for Nef, which is one of the most immuno-
genic HIV proteins. The structural data reported here
provide further useful information for the future struc-
ture-based drug design of specific inhibitors and the
development of an optimal vaccine strategy.
Materials and methods
Crystallization and data collection
The HIV-1LAI Nefcore domain (residues 58–206) and Fyn SH3 domain
(residues 72–142) were expressed in Escherichia coli as glutathione S-
transferase fusion proteins. A detailed account of protein preparation,
purification and crystallization will be given elsewhere (PF et al., unpub-
lished data). Two crystal forms were used for structure determination.
Firstly, unliganded HIV-1 Nef formed cubic crystals belonging to space
group P23 (a = b = c = 86.4 Å); a single Nef molecule was present per
asymmetric unit. A selenomethionyl version of the protein was purified
and crystallized under conditions identical to those for the native unli-
ganded protein. Two additional mercury heavy-atom derivatives were
prepared by controlled soaking. Secondly, Nef cocrystallized with Fynwt
SH3 formed hexagonal crystals that grew in space group P6522
(a = b = 108.2 Å, c = 223.7 Å). Data for the cubic and the hexagonal
crystal forms were collected to 3.0 Å resolution at the ESRF synchro-
tron radiation source (Beamline D2AM, Grenoble, France) on CCD
detector at λ = 1.0373 Å and λ = 0.9783 Å (native 1 and derivatives;
Table 2). The data collection was performed on flash frozen crystals
except for native 1 and heavy-atom derivatives of the cubic crystal form
(Table 2). The X-ray diffraction images were processed by the program
XDS [65] adapted for the D2AM beamline. Structure factor analysis
were carried out with the CCP4 suite [66]. 
Structure determination
Both multiple isomorphous replacement (MIRAS) and molecular
replacement (MR) methods were used to solve the structure of
unbound Nef cubic crystals. Refinement of heavy-atom parameters and
phase-angle calculations (Table 2) were performed with the program
MLPHARE (CCP4). MIRAS phases gave a mean overall figure of merit
of 0.43 at 3.1 Å and were significantly improved by the process of
solvent flattening and histogram matching as implemented in the
program DM (CCP4). The electron-density map with a 3.1 Å resolution
limit, however, was poor. Several secondary structure elements (two β
strands and two α helices) were identifiable and could be built in the
idealized map. They were confirmed by the MR solution. An anomalous
Fourier map gave one peak corresponding to selenium in residue
Met79. MR was performed with the AMoRe program [67] starting from
the the structure of HIV-1NL43 Nefcore [41] (PDB entry 1EFN) as a
search model. A single clear solution gave an Rfactor of 39% and a cor-
relation coefficient of 0.67 within the range of 8 Å to 3.2 Å, whereas
the next solution had an Rfactor of 55% and a correlation coefficient of
0.29. Model and MIRAS phases were combined at the beginning of
refinement in order to minimize the bias from the initial model. 
The structure of the HIV-1LAI Nef–Fynwt SH3 complex was determined
by MR using the AMoRe program [67]. The crystal structures of Fyn
SH3 [47] (SH3-B molecule in PDB entry 1SHF) and HIV-1NL43 Nefcore
[41] (PDB entry 1EFN) were used as molecular templates. Both enan-
tiomeric space groups P6122 and P6522 were tried in MR runs.
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Table 2
Data collection and phasing statistics.
Unliganded Nef Nef–SH3 complex
Native 1 SeMet HgAc PCMB Cryo
Diffraction limit (Å) 3.1 3.5 3.4 3.1 3.0 3.0
No. unique reflections 3812 2472 2786 3731 3998 14 778
Observations 18 555 12 587 11 333 15 489 20 384 57 175
Completeness (%) 93 86 89 91 92 91
Rsym (%)* 7.2 7.1 7.8 6.8 6.6 6.7
Rderiv (%)† – 14.5 21.4 23.2
Phasing power‡ – 1.2 0.9 0.8
Space group P23, a = b = c = 86.4 Å P6522, a = b = 108.2 Å c = 223.7 Å
Asymmetric unit content Z = 1 with Vm = 3.1 Å3/Da Z = 1, 1 SH3/2 Nef, Vm = 4.2 Å3/Da
*Rsym = Σ Σi | Ii– < I > | / Σ < I >, where Ii are the intensity
measurements for a reflection and < I >  is the mean value for this
reflection. †Rderiv = Σ | FPH–FP | / Σ FP, where FPH and FP represent the
structure-factor amplitude of the derivative and native crystals,
respectively. ‡Phasing power = root mean square fH/E, where fH = the
mean calculated heavy-atom structure-factor amplitude and E = the
residual lack of closure error.
Despite an extensive search, clear solutions were detected in space
group P6522 for two Nef molecules but only for one Fyn SH3 mol-
ecule. Following rigid-body refinement using the AMoRe program, the
correct solution for the three molecules had a correlation coefficient of
0.60 and an Rfactor of 35.7% within the range of 12 Å to 3.5 Å. Consis-
tent results were obtained using various resolution ranges. All positions
proposed by AMoRE for the second SH3 molecule were incorrect in
terms of crystal packing and did not lead to a significantly higher corre-
lation. The unliganded Nef molecule (Nef-A) and SH3-bound Nef mol-
ecule (Nef-B) are related by an approximate local twofold axis that is
0.4° off 180° rotation and 0.3 Å off zero translation.
Model building and refinement
The unliganded Nef model in the cubic crystal form (Nef-C) was refined
by several rounds of molecular dynamics and energy minimization with
X-PLOR [68] against the native 2 data set (Table 2), followed by
manual rebuilding. Group temperature-factor refinement was carried
out for each residue. The present model consists of 895 nonhydrogen
atoms. No solvent molecules were added to the structure. The N-termi-
nal residues 58–74 and residues 148–178, that belong to a mobile
loop, could not be traced in the current electron-density maps. The final
R factor of the refined model is 22.4% (Rfree = 28.1%) and the stereo-
chemistry is reasonable (Table 3).
The MR model for the complex Nef–Fyn SH3 in the hexagonal crystal
form consisted of two Nefcore molecules and only one Fyn SH3 domain.
The expected second SH3 domain could not be retrieved by noncrystal-
lographic symmetry (NCS) electron-density averaging. Close examination
in the final refinement cycles of the electron-density maps using 2Fo–Fc
and Fo–Fc coefficients, did not reveal any significant residual density.
NCS restraints on both Nef molecules, except for the polyproline region
(residues 71–77), were kept throughout the refinement and only
released at the final step. The final model comprises one complex, the
Fyn SH3 domain (residues 85–141) bound to a Nef-B molecule
(residues 71–148 and 178–203), and one single unliganded Nef mol-
ecule (Nef-A, residues 74–147 and 179–203). After extensive
refinement, some strong residual density was found in the crevice
between the two Nef molecules of the asymmetric unit. As Nef–Fyn
cocrystal formation depends crucially on the presence of β-octyl α-D-glu-
coside, this density is likely to represent this detergent molecule and was
modelled accordingly. The glucose moiety of this detergent molecule is
confined in a hydrophilic environment formed by the residues Asp108,
Gln104, Asp111 and Asn126, whereas the lipid tail is partially disor-
dered. This same cavity was seen to bind a trimethyl lead ion in the
FynR96I–Nefcore [41] structure. Refinement statistics are given in Table 3.
The program O [69] was used for model building and graphical display
of the molecules and electron-density maps. The stereochemistry of the
models was monitored with the program PROCHECK [70].
Accession numbers
The coordinates for the free Nef and Nef–Fynwt SH3 structures have
been deposited in the Protein Data Bank with accession codes 1avv
and 1avz, respectively.
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